Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt

Journal of the American Society of Nephrology

Volumn 19, Issue 2, 2008, Pages 380-387

  Zeng, Rui ^a   Yao, Ying ^a   Han, Min ^a   Zhao, Xiaoqin ^a   Liu, Xiao Cheng ^a   Wei, Juncheng ^a   Luo, Yun ^a   Zhang, Juan ^a   Zhou, Jianfeng ^a   Wang, Shixuan ^a   Ma, Ding ^a,b   Xu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN REDUCTASE; BIOLOGICAL MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FIBRIN FORMATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY FAILURE; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; MESENCHYME CELL; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION;

EID: 39049128068     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2006111194     Document Type: Article

References (30)

1. Beale SI, Cornejo J: Enzymatic heme oxygenase activity in soluble extracts of the unicellular red alga, Cynidium caldarium. Arch Biochem Biophys 235: 371-384, 1984
2. Maines MD: New insights into biliverdin reductase functions: Linking heme metabolism to cell signaling. Physiology 20: 382-389, 2005
3. Fakhrai H, Maines MD: Expression and characterization of a cDNA for rat kidney biliverdin reductase. Evidence suggesting the liver and kidney enzymes are the same transcript product. J Biol Chem 267: 4023-4029, 1992
4. Maines MD, Polevoda BV, Huang TJ, McCoubrey WK, Jr: Human biliverdin IX alpha reductase is a zinc-metalloprotein. Characterization of purified and Escherichia coli expressed enzymes. Eur J Biochem 235: 372-381, 1996
5. Salim M, Brown-Kipphut BA, Maines MD: Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation. J Biol Chem 276: 10929-10934, 2001
6. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD: Human biliverdin reductase: A member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci USA 17; 102: 7109-7114, 2005
7. Maines MD, Ewing JF, Huang TJ, Panahian N: Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J Pharmacol Exp Ther 296: 1091-1097, 2001
8. Ahmad Z, Salim M, Maines, MD: Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.J Biol Chem 277: 9226-9232, 2002
9. Kravets A, Hu Z, Miralem T, Torno MD, Maines, MD: Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. J Biol Chem, 279: 19916-19923, 2004
10. Kravets A, Hu Z, Miralem T, Torno MD, Maines MD: Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002
11. Backer JM, Myers MG, Jr., Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J: Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 3469-3479, 1992
12. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003
13. Larue L, Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24: 7443-7454, 2005
14. Miralem T, Hu ZB, Torno MD, Lelli KM, Maines MD: Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 280: 17084-17092, 2005
15. Liu Y, Liu J, Tetzlaff W, Paty DW, Cynader MS: Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis. Free Radic Biol Med 40: 960-967, 2005
16. Juurlink BH: Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev 21: 151-166, 1997
17. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB: Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571-2583, 1997
18. Blokhina O, Virolainen E, Fagerstedt KV: Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot (Lond) 91: 179-194, 2003
19. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M: Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65: 871-880, 2004
20. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006
21. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919, 2000
22. Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M: Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 15: 1277-1288, 2004
23. Zhang B, Liang X, Shi W, Ye Z, He C, Hu X, Liu S: Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 5/6 subtotal nephrectomy of rats. Nephrology 10: 351-357, 2005
24. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
25. Stutz F, Muller Ga: Transdifferentiation comes of age. Nephrol Dial Transplant 15: 1729-1731, 2000
26. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY: Tubular epithelial myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54: 864-876, 1998
27. Farrera JA, Jauma A, Ribo JM, Peire MA, Parellada PP, Roques-Choua S, Bienvenue E, Seta P: The antioxidant role of bile pigments evaluated by chemical tests. Bioorg Med Chem 2: 181-185, 1994
28. Neuzil J, Stocker R: Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 269: 16712-16719, 1994
29. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001
30. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999